About the Reis Lab
The Reis Research Lab is focused on translational research of solid cancers, especially of the urinary tract, including urachal cancer. We put emphasis on molecular methods to gain further insights from a pathologist's perspective.
The Reis Lab / Genitourinary Tumor Research Group aims for a better understanding of the molecular mechanisms and their predictive value for personalized therapy approaches in solid cancers, focussed on genitourinary tumors. Most projects are in bladder cancer, but also in prostate and renal cancer. A specialty of the group is its strong interest in urachal cancer, which is a very rare and aggressive cancer. Please also visit our network site urachalcancer.org. In addition to the Research Lab, Prof. Reis is the medical head of the Department of Molecular Pathology at the Dr. Senckenberg Institute of Pathology. We offer a well-equipped research infrastructure.
The Team
Prof. Henning Reis, MD
Lab Director
Henning Reis is the lab director and senior consultant pathologist sub-specialized in genitourinary pathology. He is the medical director of the department of molecular pathology at the Dr. Senckenberg Institute of Pathology.
Links: CV (de) Orcid GoogleScholar
Dr. Florestan Koll, MD
PostDoc Researcher
Florestan Koll is a postdoc researcher and consultant urologist . He is funded as a Clinician Scientist by the Mildred-Scheel-Nachwuchszentrum (MSNZ) and recently spent his postDoc time at the Memorial Sloan Kettering Cancer Center in New York.
open
Technician
The position is currently open (June 2024). Please apply, the official job posting will follow in 1-2 weeks.
Lillian Weers
Doctoral candidate
Lillian Weers works on a comprehensive analysis of lymphoepithlial urothelial carcinomas.
Leon Herwig
Doctoral candidate
Leon Herwig works on the influence of ferroptosis in ajduvant chemotherapy in urothelial bladder cancer.
Tatjana Hintz
Doctoral candidate
Tatjana Hintz will work on the comprehensive analysis of microscopic urachal remnants to obtain more data on the etiology of urachal cancer.